JENNIFER HOOK: Open Payments
NPI 1033662044 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,953 in 144 payments from 32 companies in 2025. Trend: 2023 $1,348 · 2024 $3,508 · 2025 $3,953
Food & beverage: $3,953
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $499 |
| ABBVIE INC. | 12 | $312 |
| Lundbeck LLC | 7 | $288 |
| Eisai Inc. | 4 | $277 |
| Novo Nordisk Inc | 10 | $262 |
| Otsuka America Pharmaceutical, Inc. | 12 | $257 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $252 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $210 |
| Axsome Therapeutics, Inc. | 4 | $189 |
| Exact Sciences Corporation | 6 | $182 |
Products named: REXULTI, Leqembi, CAPLYTA, VRAYLAR, VYEPTI, Kerendia, Wegovy, FARXIGA.
Industry payments across IA — which companies pay providers there.
